Ro.co vs Hims: Compare GLP-1 Programs & Pricing
Side-by-side Ro.coand Hims: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Ro.co and Hims are two established telehealth providers that offer GLP-1–based weight-management programs through virtual visits and prescription dispensing. This comparison highlights program structure, pricing visibility, membership rules, clinical oversight, and safety considerations so you can make an informed choice.
Ro.co vs Hims: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Ro.co | Not publicly listed | Not publicly listed | Brand med access | $145.00 — Yes |
| Hims | Not publicly listed | Not publicly listed | — | — |
Prices for compounded GLP-1 options can vary over time and by formulation. When a provider lists a clear starting price, we bold the lower published value; where no public price is listed, we note that directly so you can confirm cost during intake.
Ro.co vs Hims: Medical Process & Accessibility
Ro.co typically offers rapid telehealth intake, an online medical questionnaire, clinician review, and prescription fulfillment through partnered pharmacies when clinically appropriate. Hims follows a similar telehealth workflow with structured follow-up messaging and options for dose adjustments based on ongoing clinician review. Both platforms require a prescription from a licensed clinician and will not prescribe GLP-1 medications without an appropriate evaluation.
Ro.co vs Hims: Pricing Comparison
Publicly posted starting prices for semaglutide and tirzepatide formulations are not always available from every telehealth provider. In this comparison the specific starting fees for semaglutide and tirzepatide were not published on both sites at the time of writing. Ro.co does list a membership requirement and a membership fee of $145.00; Hims does not publicly display a membership fee in the same way. If pricing is your primary concern, confirm the current medication and shipping costs during clinician intake before enrollment.
Ro.co vs Hims: Clinical Oversight & Support
Both providers connect patients with licensed U.S. clinicians. Clinicians evaluate medical history, current medications, and risk factors before deciding whether a GLP-1 therapy is appropriate. Expect questions about diabetes, cardiovascular history, pregnancy status, and other contraindications. Both platforms provide follow-up communications; Hims often emphasizes ongoing dose adjustments and messaging, while Ro.co highlights rapid access and streamlined onboarding.
Ro.co vs Hims: Medication Quality & Safety
Telehealth providers typically dispense FDA-approved branded GLP-1 drugs when available or legally prescribed compounded alternatives from accredited U.S. pharmacies. Compounded formulations are not identical to branded products such as Wegovy® (semaglutide) or Mounjaro® (tirzepatide). All prescribing is subject to clinician review; neither provider should be used as a substitute for urgent medical care. Always disclose your full medical history and current medications to minimize risk.
Ro.co vs Hims: Customer Experience
User feedback often highlights Ro.co for streamlined sign-up and transparent membership fees, while reviewers commonly praise Hims for attentive clinician follow-up and patient education. Shipping times, refill options, and customer service responsiveness can fluctuate; check real-time reviews and ask each provider about expected delivery timing and pharmacy partners.
Ro.co vs Hims: Final Verdict
Choose Ro.co if quick onboarding and a clear membership model are priorities. Choose Hims if ongoing clinician messaging and structured follow-up are more important to you. Both are licensed telehealth services that require clinician evaluation and prescription; neither should be perceived as a guaranteed route to any specific medical outcome. Verify current pricing, membership terms, and medication availability during intake.
Join Ro.co
Get Started with Hims
Disclaimer
This article is for informational purposes only and does not constitute medical advice. GLP1Talks & GLP1Discussions may receive affiliate compensation. All GLP-1 prescriptions require evaluation by a licensed clinician; discuss risks, benefits, and alternatives with your healthcare provider before beginning any treatment.